RaySearch Laboratories AB (publ), commonly referred to as RaySearch, is a leading innovator in the field of radiation therapy software solutions. Headquartered in Stockholm, Sweden, the company has established a strong presence in major operational regions across Europe, North America, and Asia. Founded in 2000, RaySearch has achieved significant milestones, including the development of advanced treatment planning systems that enhance precision in cancer care. The company’s core products, such as RayStation and RayCare, are distinguished by their integration of cutting-edge technology and user-friendly interfaces, enabling healthcare professionals to deliver personalised treatment plans efficiently. With a commitment to improving patient outcomes, RaySearch has positioned itself as a key player in the oncology software market, recognised for its innovative contributions and robust partnerships within the healthcare sector.
How does RaySearch Laboratories AB (publ)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
RaySearch Laboratories AB (publ)'s score of 54 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, RaySearch Laboratories AB (publ) reported total carbon emissions of approximately 43,400 kg CO2e from Scope 2 (location-based) and 2,660 kg CO2e from Scope 1. Additionally, Scope 3 emissions amounted to about 7,770 kg CO2e, with 2,040 kg CO2e attributed to purchased goods and services. Comparatively, in 2023, the company recorded Scope 1 emissions of 5,470 kg CO2e, Scope 2 emissions of approximately 44,400 kg CO2e (location-based), and Scope 3 emissions of about 7,610 kg CO2e, with 930 kg CO2e from purchased goods and services. In 2022, total emissions were significantly higher, with Scope 1 at 6,650 kg CO2e, Scope 2 at 39,100 kg CO2e, and Scope 3 emissions reaching approximately 285,300 kg CO2e. Despite these figures, RaySearch Laboratories has not set specific reduction targets or initiatives as part of their climate commitments. The company does not currently participate in the Science Based Targets initiative (SBTi) or other formal climate pledges. Overall, while RaySearch Laboratories has made strides in tracking and reporting emissions, further commitments and reduction strategies may be necessary to align with industry standards for climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 6,650 | 0,000 | 0,000 |
| Scope 2 | 39,100 | 00,000 | 00,000 |
| Scope 3 | 285,300 | 0,000 | 0,000 |
RaySearch Laboratories AB (publ)'s Scope 3 emissions, which increased by 2% last year and decreased by approximately 97% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 16% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the primary emissions source at 26% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RaySearch Laboratories AB (publ) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
